ArticleCancer science2014

Deflection of vascular endothelial growth factor action by SS18-SSX and composite vascular endothelial growth factor- and chemokine (C-X-C motif) receptor 4-targeted therapy in synovial sarcoma.

Toru Wakamatsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.